Imprint Medicine ApS: Financial statements 2026
CVR: 45469964
Source: annual report 2026, Danish Business Authority
06/03/2025 – 31/03/2026
Imprint Medicine ApS (CVR 45469964) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK -925,659 and a net result of DKK -1,962,610. Equity in the 2026 report amounted to DKK -1,941,610. The company had 3 employees in the financial year.
- Gross Profit
- DKK -925,659
- Profit/Loss
- DKK -1,962,610
- Equity
- DKK -1,941,610
- Total Assets
- DKK 2,495,071
- Employees
- 3
Official annual report
Find more companies like Imprint Medicine ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2026
As of May 27, 2026, Cedra Godkendt Revisionsaktieselskab has been appointed auditor of Imprint Medicine ApS.
About Imprint Medicine ApS
Imprint Medicine ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2025. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Emil Christian Fischer, Faizaan Mohammad and Peter Ahn Mouritzen. The company is owned by Ahn Capital ApS, ECF Holding ApS and Shams ApS. The company has 4 employees (2026). In 2026, the company reported a gross profit of DKK -925,659 and a net result of DKK -1,962,610. Equity in the 2026 report amounted to DKK -1,941,610.